{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:46:12Z","timestamp":1740894372706,"version":"3.38.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.acuroe.2025.501701","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:24:44Z","timestamp":1739233484000},"page":"501701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-1448","authenticated-orcid":false,"given":"G.","family":"Marcq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kassouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roumigui\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Albisinni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cimadamore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yuen-Chun Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gallioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"d\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Beauval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pouessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sargos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ploussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2025.501701_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2020.08.024","volume":"79","author":"Pfister","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bju.12447","article-title":"Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone","volume":"114","author":"Mertens","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2025.501701_bib0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4143\/crt.2021.365","article-title":"The prognosis and the role of adjuvant chemotherapy for node-positive bladder cancer treated with neoadjuvant chemotherapy followed by surgery","volume":"54","author":"Jeong","year":"2022","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.acuroe.2025.501701_bib0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2008.07.035","article-title":"Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy","volume":"73","author":"Kassouf","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2025.501701_bib0040","doi-asserted-by":"crossref","first-page":"274.e15","DOI":"10.1016\/j.urolonc.2022.02.002","article-title":"Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder","volume":"40","author":"Bharadwaj","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061962","article-title":"Survival outcomes of patients with pathologically proven positive lymph nodes at time of radical cystectomy with or without neoadjuvant chemotherapy","volume":"9","author":"Ploussard","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.acuroe.2025.501701_bib0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.euo.2018.12.013","article-title":"Incidence, patterns, and outcomes with adjuvant chemotherapy for residual disease after neoadjuvant chemotherapy in muscle-invasive urinary tract cancers","volume":"3","author":"Chanza","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0055","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.clgc.2014.11.006","article-title":"Management of node-positive bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a survey of current UK practice","volume":"13","author":"Tan","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.acuroe.2025.501701_bib0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eururo.2021.09.028","article-title":"Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis of individual participant data from randomised controlled trials","volume":"81","author":"Burdett","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/BLC-180163","article-title":"The role of adjuvant radiation therapy in locally advanced bladder cancer","volume":"4","author":"Lewis","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.acuroe.2025.501701_bib0070","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuroe.2025.501701_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/BLC-170107","article-title":"Use of adjuvant chemotherapy in patients with advanced bladder cancer after neoadjuvant chemotherapy","volume":"3","author":"Sui","year":"2017","journal-title":"Bladder Cancer Amst Neth"},{"key":"10.1016\/j.acuroe.2025.501701_bib0080","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00345-016-1825-3","article-title":"Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy","volume":"34","author":"Zargar-Shoshtari","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaoncol.2017.2374","article-title":"Adjuvant chemotherapy vs observation for patients with adverse pathologic features at radical cystectomy previously treated with neoadjuvant chemotherapy","volume":"4","author":"Seisen","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0090","article-title":"Adverse pathology after neoadjuvant chemotherapy and radical cystectomy: the role of adjuvant chemotherapy","author":"Parker","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.acuroe.2025.501701_bib0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","article-title":"Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial","volume":"75","author":"Gschwend","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.urolonc.2019.05.021","article-title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a systematic review","volume":"37","author":"Iwata","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acuroe.2025.501701_bib0105","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1002\/cam4.2102","article-title":"Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer","volume":"8","author":"Fischer-Valuck","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.acuroe.2025.501701_bib0110","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.euf.2021.11.004","article-title":"Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer: results of a multicentric phase II trial","volume":"8","author":"Fonteyne","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.acuroe.2025.501701_bib0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clon.2021.03.020","article-title":"Adjuvant and neoadjuvant radiation therapy for locally advanced bladder cancer","volume":"33","author":"Baumann","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.acuroe.2025.501701_bib0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.4591","article-title":"Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 trial","volume":"153","author":"Zaghloul","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.acuroe.2025.501701_bib0125","unstructured":"FDA approves nivolumab for adjuvant treatment of urothelial carcinoma. 2021 [Accessed 18 April 2022]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-nivolumab-adjuvant-treatment-urothelial-carcinoma."},{"key":"10.1016\/j.acuroe.2025.501701_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357862500006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357862500006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T14:33:44Z","timestamp":1740839624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217357862500006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S217357862500006X"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501701","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501701","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEU.","name":"copyright","label":"Copyright"}],"article-number":"501701"}}